Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies.

MLA

Molinuevo, María Silvina, et al. “Effects of Advanced Glycation End-Products, Diabetes and Metformin on the Osteoblastic Transdifferentiation Capacity of Vascular Smooth Muscle Cells: In Vivo and in Vitro Studies.” Journal of Diabetes and Its Complications, vol. 37, no. 11, Nov. 2023, p. 108626. EBSCOhost, https://doi.org/10.1016/j.jdiacomp.2023.108626.

APA

Molinuevo, M. S., Cortizo, A. M., & Sedlinsky, C. (2023). Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies. Journal of Diabetes and Its Complications, 37(11), 108626. https://doi.org/10.1016/j.jdiacomp.2023.108626

Chicago

Molinuevo, María Silvina, Ana María Cortizo, and Claudia Sedlinsky. 2023. “Effects of Advanced Glycation End-Products, Diabetes and Metformin on the Osteoblastic Transdifferentiation Capacity of Vascular Smooth Muscle Cells: In Vivo and in Vitro Studies.” Journal of Diabetes and Its Complications 37 (11): 108626. doi:10.1016/j.jdiacomp.2023.108626.